Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Pryor (Apalutamide) 60mg Tablets
Pryor (Apalutamide) 60mg Tablets, manufactured by Zydus Cadila, is a specialized medication indicated for the treatment of prostate cancer, providing targeted therapy to inhibit cancer cell growth.
Uses of Pryor (Apalutamide) 60mg Tablets
Pryor (Apalutamide) 60mg Tablets are used for:
Treatment of non-metastatic castration-resistant prostate cancer (nmCRPC).
Administration in combination with androgen deprivation therapy (ADT) for metastatic castration-sensitive prostate cancer (mCSPC).
Benefits of Pryor (Apalutamide) 60mg Tablets
Delays disease progression and prolongs metastasis-free survival in prostate cancer patients.
Reduces the risk of cancer spread and improves overall survival outcomes.
Offers a convenient oral formulation, enhancing patient adherence and quality of life during treatment.
Mechanism of Action of Pryor (Apalutamide) 60mg Tablets
Pryor (Apalutamide) 60mg Tablets contain apalutamide, a next-generation androgen receptor inhibitor. It competitively inhibits androgen binding and impairs androgen receptor translocation, thereby blocking androgen receptor signaling. This mechanism suppresses prostate cancer cell growth and promotes cancer regression.
Beside this well also export in other countries